Table 1.
Variable | TZQ-F Group | Placebo Group | Acarbose Group |
---|---|---|---|
(n=15) | (n=15) | (n=16) | |
Sex (M/F) | 8/7 | 12/3 | 9/7 |
Age (year) | 62.93±6.11 | 57.40±9.74 | 58.07±5.23 |
BMI (kg/m2) | 26.99±3.17 | 28.56±3.87 | 25.90±2.27 |
Waistline (cm) | 95.43±11.24 | 100.23±8.36 | 94.87±8.44 |
HbA1c (%) | 7.64±0.81 | 7.59±1.03 | 7.25±0.79 |
FINS (mIU/L) | 16.64±8.65 | 15.00±7.07 | 15.10±14.57 |
FBG (mmol/L) | 7.44±1.17 | 7.75±1.07 | 7.62±1.17 |
OGTT2hBG (mmol/L) | 13.96±4.02 | 13.76±3.15 | 13.91±4.68 |
TG (mmol/L) | 1.52±0.61 | 2.06±1.05 | 2.35±1.38 |
TC (mmol/L) | 4.92±0.70 | 4.87±0.82 | 4.74±0.78 |
LDL-C (mmol/L) | 2.86±0.52 | 2.87±0.61 | 2.59±0.63 |
HDL-C (mmol/L) | 1.38±0.39 | 1.17±0.25 | 1.22±0.35 |
Note: data were analyzed using ANOVA. p>0.05 (among three groups). FBG: fasting blood glucose; OGTT 2hBG: oral glucose tolerance test 2 h blood glucose; HbA1c: glycosylated hemoglobin; BMI: body mass index; TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol.